Literature DB >> 18296418

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

J-Y Blay, H El Sayadi, P Thiesse, J Garret, I Ray-Coquard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296418     DOI: 10.1093/annonc/mdn033

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  42 in total

1.  Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future.

Authors:  Sherif S Morgan; Lee D Cranmer
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

Review 2.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

3.  Pigmented villonodular synovitis responsive to imatinib therapy.

Authors:  Wynne M Snoots; David Watkins; Dee Dockery; Robert Mennel; Brennen Scott Cheek
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

Review 4.  First-Line Therapy for Metastatic Soft Tissue Sarcoma.

Authors:  Megan Meyer; Mahesh Seetharam
Journal:  Curr Treat Options Oncol       Date:  2019-01-24

5.  A rare case of localised pigmented villonodular synovitis in the knee of a 24-year-old female soccer player: diagnosis, management and summary of tenosynovial giant cell tumours.

Authors:  Casper Falster; Simon Stockmann Poulsen; Uffe Joergensen
Journal:  BMJ Case Rep       Date:  2017-10-04

6.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

7.  Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Authors:  Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

8.  Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Authors:  Hongwei Cheng; Paul W Clarkson; Dongxia Gao; Marina Pacheco; Yuzhuo Wang; Torsten O Nielsen
Journal:  Sarcoma       Date:  2010-10-13

9.  Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

Authors:  Robert G Maki; David R D'Adamo; Mary L Keohan; Michael Saulle; Scott M Schuetze; Samir D Undevia; Michael B Livingston; Matthew M Cooney; Martee L Hensley; Monica M Mita; Chris H Takimoto; Andrew S Kraft; Anthony D Elias; Bruce Brockstein; Nathalie E Blachère; Mark A Edgar; Lawrence H Schwartz; Li-Xuan Qin; Cristina R Antonescu; Gary K Schwartz
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

10.  Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: clinical series and outcome.

Authors:  Jitesh K Jain; J V S Vidyasagar; Radha Sagar; Hiren Patel; Matad Lokeshwaraiah Chetan; Ashish Bajaj
Journal:  Int Orthop       Date:  2013-07-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.